title: Molecular and physiological study of the artificial maturation process in European eel males: from brain to testis.
abstract: European eel males can be artificially matured (1.5IU hCG/g fish), but the regulatory mechanisms of their reproductive development are practically unknown. Spermatogenic stages (S1-S6), biometric characters [eye index (EI), gonadosomatic index (GSI), hepatosomatic index (HSI)] and sperm quality parameters (motility, viability and head spermatozoa morphometry) were analysed. Moreover, the present study evaluated the expression of GnRHs (mammal and chicken II Gonadotropin Release Hormone I) and gonadotrophins (FSHbeta and LHbeta) during hormonal treatment, as well as 11-ketotestosterone (11-KT) and 17,20beta-dihydroxy-4-pregnen-3-one (17,20beta-P) plasma levels. One week was enough to observe the S2 of gonad development, but it was necessary to reach the 7th week of treatment to obtain animals that presented the most advanced stage of development (S6). Differential regulation of the two GnRH expressions was found, supporting the main role of mGnRH in the control of gonadotrophin release. One hCG injection was enough to dramatically decrease the FSHbeta expression, being close to zero during the rest of the treatment. LHbeta expression and 17,20beta-P registered a significant increase in the same stage of development, S3/4, confirming the role of this gonadotrophin in the last steps of maturation and 17,20beta-P in the spermatozoa maturation. The 11-KT increased with GSI, and the highest 11-KT values coincided with the advanced steps of spermatogenesis prior to spermiation. Being consistent with the known role of the steroid in these processes. Furthermore, this study supports a role for 11-KT in stimulating eye growth, presenting high values when EI increased. Sperm production was obtained from the 4th week of treatment, but it was in the 8th week when a significant increase was observed in sperm quality [viability, high motility (>75%)].
authors.affiliation: Grupo de Acuicultura y Biodiversidad, Instituto de Ciencia y Tecnología Animal, Universidad Politécnica de Valencia, Camino de Vera s/n, 46022 Valencia, Spain.
authors.forename: David S
authors.initials: DS
authors.lastname: Peñaranda
authors.forename: Luz
authors.initials: L
authors.lastname: Pérez
authors.forename: Víctor
authors.initials: V
authors.lastname: Gallego
authors.forename: Miguel
authors.initials: M
authors.lastname: Jover
authors.forename: Helge
authors.initials: H
authors.lastname: Tveiten
authors.forename: Sylvie
authors.initials: S
authors.lastname: Baloche
authors.forename: Sylvie
authors.initials: S
authors.lastname: Dufour
authors.forename: Juan F
authors.initials: JF
authors.lastname: Asturiano
mesh_terms: D000811:Anguilla; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006063:Chorionic Gonadotropin / Q000378:metabolism / Q000494:pharmacology; D005123:Eye / Q000187:drug effects; D037201:Follicle Stimulating Hormone, beta Subunit / Q000235:genetics*; D007987:Gonadotropin-Releasing Hormone / Q000235:genetics*; D006908:Hydroxyprogesterones / Q000097:blood; D037101:Luteinizing Hormone, beta Subunit / Q000235:genetics*; D008297:Male; D013091:Spermatogenesis / Q000187:drug effects; D013094:Spermatozoa / Q000187:drug effects / Q000502:physiology; D013737:Testis / Q000187:drug effects / Q000502:physiology*; D013739:Testosterone / Q000031:analogs & derivatives / Q000097:blood
chemical_list: D006063:Chorionic Gonadotropin; D037201:Follicle Stimulating Hormone, beta Subunit; D006908:Hydroxyprogesterones; D037101:Luteinizing Hormone, beta Subunit; C007433:17,20-dihydroxy-4-pregnen-3-one; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; C003600:11-ketotestosterone